• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑郁症状与精神分裂症:一种精神药理学方法

Depressive symptoms and schizophrenia a psychopharmacological approach.

作者信息

Mauri M C, Bravin S, Fabiano L, Vanni S, Boscati L, Invernizzi G

机构信息

Department of Clinical Psychiatry, University of Milan, Italy.

出版信息

Encephale. 1995 Sep-Oct;21(5):555-8.

PMID:8529564
Abstract

The frequency of depression was assessed in 43 chronic schizophrenic patients during an acute exacerbation phase of schizophrenia. The dexamethasone suppression test was administered to all patients. Depressive symptomatology showed a prevalence from 16.3% for moderate symptoms to 23.3% for mild ones. Depressive symptoms occurred concurrently with the psychotic picture and resolved as the psychosis remitted. Depressive symptoms were not relative to age, sex, duration of illness, DST cortisol levels, drug dosages and extrapyramidal side effects while basal cortisol levels were negatively correlated with basal Hamilton score.

摘要

在43例处于精神分裂症急性加重期的慢性精神分裂症患者中评估抑郁的发生率。对所有患者进行地塞米松抑制试验。抑郁症状的患病率为中度症状16.3%,轻度症状23.3%。抑郁症状与精神病症状同时出现,并随着精神病症状的缓解而消失。抑郁症状与年龄、性别、病程、地塞米松抑制试验皮质醇水平、药物剂量和锥体外系副作用无关,而基础皮质醇水平与基础汉密尔顿评分呈负相关。

相似文献

1
Depressive symptoms and schizophrenia a psychopharmacological approach.抑郁症状与精神分裂症:一种精神药理学方法
Encephale. 1995 Sep-Oct;21(5):555-8.
2
Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.胃肠外给予氟哌啶醇以快速控制急性精神分裂症的严重、扰乱性症状。
Dis Nerv Syst. 1974 Mar;35(3):112-5.
3
Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.精神病性抑郁的精神药理学关联:门诊精神分裂症患者中氟哌啶醇与替沃噻吨的双盲研究
J Clin Psychiatry. 1982 Mar;43(3):105-10.
4
Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.首发精神分裂症患者抑郁症状及其与急性治疗结局的关系:比较利培酮与氟哌啶醇的治疗效果。
World J Biol Psychiatry. 2012 Jan;13(1):30-8. doi: 10.3109/15622975.2011.552633. Epub 2011 May 13.
5
The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia.首发精神分裂症患者抑郁症状与主观幸福感的关系。
Compr Psychiatry. 2010 Mar-Apr;51(2):165-70. doi: 10.1016/j.comppsych.2009.05.004. Epub 2009 Jul 9.
6
Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.精神分裂症急性治疗中,α-1-酸性糖蛋白血浆水平与对氟哌啶醇反应之间的负相关。
Biol Psychiatry. 1995 Aug 1;38(3):198-200. doi: 10.1016/0006-3223(95)00073-P.
7
Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.非缺陷综合征中的阴性症状对抗精神病药物治疗有反应,同时血浆高香草酸浓度会发生变化。
J Psychiatry Neurosci. 1996 May;21(3):167-71.
8
Pathophysiology and treatment of negative symptoms.阴性症状的病理生理学与治疗
Can J Psychiatry. 1994 Nov;39(9 Suppl 2):S53-8.
9
Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs.精神分裂症中的抑郁:第一代和第二代抗精神病药物的比较。
Schizophr Res. 2008 Feb;99(1-3):7-12. doi: 10.1016/j.schres.2007.10.020. Epub 2007 Dec 4.
10
Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.早期精神病的口服与注射用抗精神病药物治疗:两项研究的事后比较
Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

引用本文的文献

1
Psychiatric comorbidities and schizophrenia.精神科共病与精神分裂症
Schizophr Bull. 2009 Mar;35(2):383-402. doi: 10.1093/schbul/sbn135. Epub 2008 Nov 14.
2
Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations.精神分裂症中抑郁症的心理途径:急性精神病、精神病后抑郁及幻听的研究
Eur Arch Psychiatry Clin Neurosci. 2005 Jun;255(3):202-12. doi: 10.1007/s00406-005-0588-4.